Complex Internalization, Degradation, and Recycling

Why Internalization Needs More Than One Fate

When a drug binds its target, the resulting complex may be internalized. Internalization is not, by itself, a complete description of what happens next. The target may return to the cell surface, be degraded inside the cell, or remain temporarily in an intracellular pool; the drug may be degraded intracellularly or, in a different biological system, be returned to the extracellular space. These possibilities affect target abundance and drug disposition in different ways.

The model below makes those distinctions explicit. It extends the full TMDD mass-balance framework and target synthesis and turnover by adding intracellular target and drug states. Its central simplifying assumption is that an internalized complex promptly separates into target and drug, which then follow their own intracellular fates. This is a useful model structure, not a universal description of intracellular trafficking.

All rate constants are nonnegative. Concentrations may be expressed in nM and time in hours, for example; then first-order rate constants have units h\(^{-1}\), \(k_{\mathrm{on}}\) has units nM\(^{-1}\)h\(^{-1}\), and \(k_{\mathrm{syn}}\) has units nM/h. Let \(u(t)\) denote drug input into the extracellular compartment in concentration per unit time, and let \(k_{\mathrm{el}}D\) denote nonspecific elimination of free drug.

Equations and Their Assumptions

Applying mass action to binding and first-order rates to the other processes gives the following equations:

The model assumes well-mixed compartments, one-to-one drug-target binding, and constant rate parameters over the modeled period. It treats target synthesis as input to the surface free-target pool and free-target degradation as a first-order process. Internalization removes surface complex and supplies one target equivalent to \(Q\) and one drug equivalent to \(I\). Thus it assumes prompt intracellular separation for purposes of the modeled kinetics. The model does not include intracellular complex accumulation, drug recycling, target transport delays beyond \(Q\), or drug elimination from any compartment other than free-drug elimination and degradation of \(I\).

The absence of a direct \(k_{\mathrm{int}}C\) term in the \(D\) equation is deliberate. Internalization removes complex, not free extracellular drug. It affects free drug over time by changing how much complex remains available to dissociate and return drug to the free pool. Similarly, recycling adds target back to \(R\), but does not return drug under these assumptions.

Mass-Balance Derivation

A useful check is to sum the state variables that represent each moiety. Define the modeled target amount, in concentration equivalents, as \(M_T=R+C+Q\). Add the equations for \(R\), \(C\), and \(Q\). The association terms cancel the matching dissociation terms, internalization removes \(C\) while adding \(Q\), and recycling removes \(Q\) while adding \(R\). The result is:

This is a stoichiometric balance: target can enter through synthesis and leave through the two target-degradation pathways, but binding, internalization, and recycling only move target between modeled states. The target pool need not be constant; it changes whenever synthesis and degradation fluxes do not balance.

Likewise define \(M_D=D+C+I\), the drug amount in concentration equivalents across the modeled drug states. Summing the corresponding equations gives:

Binding and dissociation cancel because they redistribute drug between \(D\) and \(C\). Internalization transfers drug from \(C\) to \(I\), so it also cancels in the sum. Drug leaves the modeled system through free-drug elimination and intracellular degradation. These balances are strong implementation checks: if the summed equations retain a binding, internalization, or recycling term, at least one state equation is inconsistent with the stated reactions.

What Recycling and Degradation Rates Mean

If \(Q\) is held at a constant input flux for long enough to reach its local steady state, and its only exits are recycling and degradation, then setting \(dQ/dt=0\) gives:

At that condition, the fraction of incoming internalized target flux that recycles is \(k_{\mathrm{rec}}/(k_{\mathrm{rec}}+k_{\mathrm{deg},T})\), and the fraction that degrades is \(k_{\mathrm{deg},T}/(k_{\mathrm{rec}}+k_{\mathrm{deg},T})\). These fractions describe competing first-order exits from \(Q\); they are not the fractions of all surface target that recycle or degrade. Their interpretation depends on the specified pathway structure and the assumption that the rates are constant.

Model Choice, Diagnostics, and Limitations

A simpler alternative is to remove complex through a single effective loss term, such as \(k_{\mathrm{int}}C\), without tracking \(Q\) or \(I\). This can be adequate when the scientific question concerns only the disappearance of surface complex, or when intracellular fates are not measured and need not be distinguished. It cannot, by itself, predict how much target returns to the surface, how much target is degraded after internalization, or how intracellular drug accumulates and degrades. The explicit-compartment model is more mechanistic, but it also adds parameters and states that may be difficult to estimate from limited data.

Useful checks include verifying that all rates have compatible units, that all states remain nonnegative under nonnegative inputs and initial conditions, and that the target and drug balance equations reduce to the expected synthesis and elimination fluxes. Compare model predictions with data over time: persistent errors in target recovery after complex declines may indicate that a single irreversible complex-loss term is inadequate. A delay in target recovery may require an intracellular target pool such as \(Q\), while systematic drug-persistence errors may indicate that drug recycling, intracellular complex, or another drug compartment is missing. Such patterns are clues, not unique diagnoses; assay error and other forms of model misspecification can produce similar discrepancies.

A common mistake is to count complex internalization as target degradation and then also include degradation from \(Q\). That removes target twice: once when \(C\) is internalized and again when \(Q\) degrades. In the model here, internalization transfers target from \(C\) to \(Q\); only \(k_{\mathrm{deg},T}Q\) and \(k_RR\) remove target. A related mistake is to omit the recycling term from \(dR/dt\) while retaining it as a loss from \(Q\). Recycling is a transfer, so it must appear with opposite signs in the two equations and cancel from the total-target balance.

The model also has important limits. The separate \(Q\) and \(I\) pools assume rapid dissociation of internalized complex and do not represent intact intracellular complex. A biological system in which the drug is recycled, target returns with drug bound, or intracellular processing is saturable needs a different reaction scheme. Finally, these equations describe disposition and target turnover; they do not specify how target engagement produces a pharmacodynamic response.